Evidence map›Paper›PMID 42604318›Full record

ArticleJTCVS open2026

Survival and outcomes of coronary artery bypass grafting in patients with extremely low ejection fraction (≤20%): A systematic review and meta-analysis.

Wenteng Hou, Iris Liu, Nader S Aboelnazar, Rashmi Nedadur, Thin Xuan Vo, A Dave Nagpal

Abstract read
In one paragraph

Article in JTCVS open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Wenteng HouSchulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.
Iris LiuSchulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.
Nader S AboelnazarSchulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.
Rashmi NedadurSchulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.
Thin Xuan VoSchulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.
A Dave NagpalSchulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: To assess perioperative outcomes and long-term survival of coronary artery bypass in patients with ejection fraction (EF) 20% or less. Methods: We performed a systematic search of MEDLINE, EMBASE, and CENTRAL via OVID for both randomized controlled trials and cohort studies involving patients with EF ≤20% undergoing coronary artery bypass grafting, including results from 1995 to December 2023. Random-effects prevalence meta-analysis was performed using the meta library in R. Outcome prevalence was logit-transformed and pooled using a generalized linear mixed-effects model. The presence of heterogeneity was assessed using the Cochran Q test with a significance of Results: A total of 29 studies involving 5910 patients were included in this analysis. The pooled prevalence of perioperative mortality was 9%. Postoperative myocardial infarction and stroke prevalence were 2% and 3%, respectively. Low cardiac output syndrome definition varied across studies, and its pooled prevalence was 16%, with postoperative mechanical circulatory support requirement at 9%, the pooled 5-year survival rate was 74%. Conclusions: Despite elevated short-term risk, patients with severely low LVEF (≤20%) may derive long-term survival benefit from coronary artery bypass grafting and therefore it should remain a consideration in advanced heart failure therapies.

Indexed as

coronary revascularizationheart failureischemic cardiomyopathy

Identifiers

PMID42604318
PMCPMC13477090

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.